# Effect of Vyvanse on Driving in Young Adults With ADHD

> **NCT00801229** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 75 (actual)

## Conditions studied

- Attention Deficit/Hyperactivity Disorder(ADHD)

## Interventions

- **DRUG:** Vyvanse
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00801229
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2014-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00801229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00801229, "Effect of Vyvanse on Driving in Young Adults With ADHD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00801229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*